Jennifer S. Temel, MD

Publications

• Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Eng
  21430269
• Jacobsen J, Jackson V, Dahlin C, Greer J, Perez-Cruz P, Billings JA, Pirl W, Temel J.Components of Early Outpatient Palliative Care Consultation in Patients with Metastatic Nonsmall Cell Lung Cancer.J Palliat Med. 2011 Mar 18.
  21417739
• Traeger L, Braun IM, Greer JA, Temel JS, Cashavelly B, Pirl WF.Parsing Depression From Fatigue in Patients with Cancer Using the Fatigue Symptom Inventory.J Pain Symptom Manage. 2011 Mar 11.
  21398085
• Krug LM, Crawford J, Ettinger DS, Shapiro GI, Spigel D, Reiman T, Temel JS, Michelson GC, Young DY, Hoch U, Adelman DC.Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer.J Thorac O
  21252718
• Chan JA, Blaszkowsky LS, Enzinger PC, Ryan DP, Abrams TA, Zhu AX, Temel JS, Schrag D, Bhargava P, Meyerhardt JA, Wolpin BM, Fidias P, Zheng H, Florio S, Regan E, Fuchs CS.A multicenter phase II trial of single-agent cetuximab in advanced esophageal and ga
  21217058
• Neal JW, Heist RS, Fidias P, Temel JS, Huberman M, Marcoux JP, Muzikansky A, Lynch TJ, Sequist LV.Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy.J T
  20975380
• Heist RS, Fain J, Chinnasami B, Khan W, Molina JR, Sequist LV, Temel JS, Fidias P, Brainerd V, Leopold L, Lynch TJ.Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer.J Thorac Oncol. 2010 Oct;5(10):1637-43.
  20808253
• Dahlin CM, Kelley JM, Jackson VA, Temel JS.Early palliative care for lung cancer: improving quality of life and increasing survival.Int J Palliat Nurs. 2010 Sep;16(9):420-3.
  20871495
• Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ.Early palliative care for patients with metastatic non-small-cell lung cancer.N Engl J Med. 2010 Aug 19;363(8):733-4
  20818875
• Temel JS, Greer JA, Admane S, Solis J, Cashavelly BJ, Doherty S, Heist R, Pirl WF.Code status documentation in the outpatient electronic medical records of patients with metastatic cancer.J Gen Intern Med. 2010 Feb;25(2):150-3.
  19894078
• El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE.Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.J Clin Oncol. 2010 Jan 10;28(2):305-10.
  19949010
• Loggers ET, Maciejewski PK, Paulk E, Desanto-Madeya S, Nilsson M, Viswanath K, Wright AA, Balboni TA, Temel J, Stieglitz H, Block S, Prigerson HG.Racial Differences in Predictors of Intensive End-of-Life Care in Advanced Cancer Patients.J Clin Oncol. 2009
  19805675
• Sequist LV, Fidias PM, Temel JS, Kolevska T, Rabin MS, Boccia RV, Burris HA, Belt RJ, Huberman MS, Melnyk O, Mills GM, Englund CW, Caldwell DC, Keck JG, Meng L, Jones M, Brown GL, Edelman MJ, Lynch TJ.Phase 1-2a multicenter dose-ranging study of canfosfam
  19701107
• Pirl WF, Greer J, Temel JS, Yeap BY, Gilman SE.Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey Replication.J Clin Oncol. 2009 Sep 1;27(25):4130-4.
  19636024
• Pirl WF, Solis J, Greer J, Sequist L, Temel JS, Lynch TJ.Epidermal growth factor receptor tyrosine kinase inhibitors and depression.J Clin Oncol. 2009 Aug 10;27(23):e49-50; author reply e51.
  19597022
• Muriel AC, Hwang VS, Kornblith A, Greer J, Greenberg DB, Temel J, Schapira L, Pirl W.Management of psychosocial distress by oncologists.Psychiatr Serv. 2009 Aug;60(8):1132-4.
  19648204
• Paddison JS, Temel JS, Fricchione GL, Pirl WF.Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis.Palliative & Supportive Care. 2009 Jun;7(2):213-7.
  19538804
• Temel JS,Greer JA,Goldberg S,Vogel PD,Sullivan M,Pirl WF,Lynch TJ,Christiani DC,Smith MR.A structured exercise program for patients with advanced non-small cell lung cancer.J Thorac Oncol. 2009 May;4(5):595-601.
  19276834
• Greer JA,Pirl WF,Park ER,Lynch TJ,Temel JS.Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer.J Psychosom Res. 2008 Dec;65(6):549-52.
  19027443
• Heist RS,Fidias P,Huberman M,Ardman B,Sequist LV,Temel JS,Lynch TJ.A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.J Thorac Oncol. 2008 Oct;3(10):1153-8.
  18827612
• Temel JS,McCannon J,Greer JA,Jackson VA,Ostler P,Pirl WF,Lynch TJ,Billings JA.Aggressiveness of care in a prospective cohort of patients with advanced NSCLC.Cancer. 2008 Aug 15;113(4):826-33.
  18618579
• Pirl WF, Temel JS, Billings A, Dahlin C, Jackson V, Prigerson HG, Greer J, Lynch TJ.Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study.Psychosomatics. 2008 May-Jun;49(3):218-24.
  18448776
• Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ.A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer.Thyroid. 2008 Mar;18(3):317-23.
  17985985
• Pirl WF, Muriel A, Hwang V, Kornblith A, Greer J, Donelan K, Greenberg DB, Temel J, Schapira L.Screening for psychosocial distress: a national survey of oncologists.J Support Oncol. 2007 Nov-Dec;5(10):499-504.
  18240673
• Bradbury PA, Heist RS, Kulke MH, Zhou W, Marshall AL, Miller DP, Su L, Park S, Temel J, Fidias P, Sequist L, Lynch TJ, Wain JC, Shepherd FA, Christiani DC, Liu G.A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic
  18199725
• Temel JS, Jackson VA, Billings JA, Dahlin C, Block SD, Buss MK, Ostler P, Fidias P, Muzikansky A, Greer JA, Pirl WF, Lynch TJ.Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.J Clin Oncol. 2007 Jun
  17557950
• Temel JS, Pirl WF, Recklitis CJ, Cashavelly B, Lynch TJ.Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic.J Thorac Oncol. 2006 Jun;1(5):454-9.
  17409899
• Shi AA, Digumarthy SR, Temel JS, Halpern EF, Kuester LB, Aquino SL.Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?.J Thorac Oncol. 2006 Mar;1(3):205-10.
  17409858
• Temel J.Complexities of quality of life analysis in non-small cell lung cancer.J Support Oncol. 2007 Jan;5(1):30-1. Review.
  17265784
• Jackman DM, Yeap BY, Lindeman NI, Fidias P, Rabin MS, Temel J, Skarin AT, Meyerson M, Holmes AJ, Borras AM, Freidlin B, Ostler PA, Lucca J, Lynch TJ, Johnson BE, Jänne PA.Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age tre
  17228019
• Temel JS, Pirl WF, Lynch TJ.Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer.Clin Lung Cancer. 2006 Jan;7(4):241-9. Review.
  16512977
• Donovan J, Temel J, Zuckerman A, Gribben J, Fang J, Pierson G, Ross A, Diller L, Grupp SA.CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies.Med Pediatr Oncol. 2000 Dec;35(6):677-82.
  11107145